The process begins with the isolation of individual cells from a tumor sample. Once isolated, each cell's RNA is reverse-transcribed into complementary DNA (cDNA), which is then amplified and sequenced. Advanced bioinformatics tools are used to analyze the data, enabling the identification of distinct cell populations based on their transcriptome.
